This episode features two renowned experts in the field of headache medicine, Dr Katy Munro, and Dr Rebecca Walker, as they delve into the fascinating world of anti-CGRP treatments for migraine.

They explore the science behind anti-CGRP and its role in migraine pathophysiology, shedding light on how these innovative treatments work to prevent and alleviate migraine attacks. They discuss the therapeutic benefits, potentially low side effects, and the overall efficacy of these treatments, providing valuable insights for both patients and healthcare providers.

Learn more about the evolving landscape of migraine management and the challenges and opportunities that lie ahead, anti-CGRP treatments such as eptinezumab (Vyepti), the gepants like rimegant (Vydura) and other upcoming treatments.

Whether you are a migraine sufferer seeking new treatment options, a healthcare professional eager to stay up to date with the latest advancements, or simply someone interested in the fascinating world of neurology, this episode offers a comprehensive and accessible exploration of anti-CGRP treatments for migraine, complemented by a poignant patient experience that highlights the transformative power of these therapies.

Visit the National Migraine Centre's website to learn more about the life changing anti-CGRP treatments available.